"In vivo" profile of novel nicotinic ligands with CNS selectivity

Medicinal Chemistry Research

Volumn 6, Issue 7-8, 1996, Pages 487-510

  Brioni, Jorge D ^a   Morgan, Sherry J ^a   O'Neill, Alyssa B ^a   Sykora, Theresa M ^a   Postl, Steve P ^a   Pan, Jia Bao ^a   Sullivan, James P ^a   Arneric, Stephen P ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0008290584     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (91)

1. tn edition", ed. A., Rall, T., Nies, A. & Taylor, P., Pergamon Press, New York, 1990, 166-187.
2. Levin, E., Conners, C., Sparrow, E., Hinton, S., Erhardt, D., Meck, W., Rose, J. and March, J., Psychopharmacology, 1996, 123, 55-63.
3. Moss, D. E., Manderscheid, P. Z., Montgomery, S. P., Norman, A. B. and Sanberg, P. R., Life Sci., 1989, 44, 1521-1525.
4. Newhouse, P. A., Sunderland, T., Tariot, P. N., Blumhardt, C. L., Weingartner, H., Mellow, A. and Murphy, D. L., Psychopharmacology, 1988, 95, 171-175.
5. Smith, C. and Giacobini, E., Rev. Neurosci., 1992, 3, 25-43.
6. Warburton, D., Prog. Neuro-Psychopharmacol. & Biol-Psychiat., 1992, 16, 181-191.
7. Martin, B. R., Martin, T. J., Fan, F. and Damaj, M. I., Med. Chem. Res., 1993, 2, 564-577.
8. Stolerman, I., in "Nicotine psychopharmacology", ed. Wonnacot, S., Russell, M. & Stolerman, I., Oxford University Press, Oxford, 1990, 279-306.
9. Brioni, J. D., Decker, M. W., Sullivan, J. P. and Arneric, S. P., Adv. Pharmacol., 1996, 37, 153-213.
10. Galzi, J., Revah, F., Bessis, A. and Changeux, J., Ann. Rev. Neurosci., 1991, 31, 37-72.
11. Williams, M., Sullivan, J. and Arneric, S., Drug News Perspectives, 1994, 7, 205-223.
12. Elgoyhen, A., Johnson, D., Boulter, J., Vetter, D. and Heinemann, S., Cell, 1994, 79, 705-715.
13. Luetje, C. and Patrick, J., J. Neurosci., 1991, 11, 837-845.
14. Arneric, S., Sullivan, J. and Williams, M., in "Psychopharmacology: Fourth generation of progress", ed.. Bloom, F. & Kupfer, D. Raven Press, New York, 1995, 95-110.
15. Deneris, E. S., Connolly, J., Rogers, S. W. and Duvoisin, R., Trends Pharmacol. Sci., 1991, 12, 34-40.
16. Papke, R., Prog. Neurobiol., 1993, 41, 509-531.
17. McGehee, D. S. and Role, L. W., Ann. Rev. Physiol., 1995, 57, 521- 546.
18. Sargent, P. B., Ann. Rev. Neurosci., 1993, 16, 403-443.
19. Gerzanich, V., Anand, R. and Lindstrom, J., Mol. Pharmacol., 1994, 45, 212-220.
20. Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B. and Kellar, K. J., Mol. Pharmacol., 1992, 41, 31-37.
21. Clarke, P. B. S., Schwartz, R. D., Paul, S. M., Pert, C. B. and Pert, A., J. Neurosci., 1985, 5, 1307-1315.
22. Schulz, D., Loring, R., Aizenman, E. and Zigmond, R., J. Neurosci., 1991, 11, 287-297.
23. Gopalakrishnan, M., Monteggia, L. M., Anderson, D. J., Arneric, S. P. and Sullivan, J. P., J. Pharmacol. Exp. Ther., 1996, 276, 289-297.
24. Papke, R. L. and Heinemann, S. F., Mol. Pharmacol., 1993, 45, 142-149.
25. Sullivan, J. P., Donnelly-Roberts, D., Anderson, D. J., Gopalakrishnan, M., Briggs, C. A., Campbell, J. E., Piattoni-Campbell, M., McKenna, D. G., Molinari, E., Holladay, M. W., Lin, N.-H. and Arneric, S. P., Neuropharmacol., 1996, in press.
26. Briggs, C., Anderson, D., Brioni, J., Buccafusco, J., Campbell, L, Decker, M., Donnelly-Roberts, D., Gopalakrishnan, M., Holladay, M., Sullivan, J. and Arneric, S., Pharmacol. Biochem. Behav., 1996, in press.
27. Seguela, P., Wadiche, J., Dineley-Miller, K., Dani, J. and Patrick, J., J. Neurosci., 1993, 13, 596-604.
28. Bertrand, D., Bertrand, S. and Ballivet, M., Neurosci. Lett., 1992, 146, 87-90.
29. Courturier, S., Bertrand, D., Matter, J. M., Hernandez, M.-C., Bertrand, S., Miller, N., Valera, S., Barkas, T. and Ballivet, M., Neuron, 1990, 5, 847-856.
30. Gopalakrishnan, M., Buisson, M., Touma, E., Giordano, T., Campbell, J., Hu, I., Donnelly-Roberts, D., Arneric, S., Bertrand, D. and Sullivan, J., Eur. J. Pharmacol., 1995, 290, 237-246.
31. Vernino, S., Amador, M., Luetje, C. W., Patrick, J. and Dani, J. A., Neuron, 1992, 8, 127-134.
32. Briggs, C. A., McKenna, D. G. and Piattoni-Kaplan, M., Neuropharmacology, 1995, 34, 583-590.
33. Wonnacott, S., Albuquerque, E. X. and Bertrand, D., Methods in Neuroscience, 1993, 12, 263-275.
34. Sullivan, J., Decker, M. W., Brioni, J. D., Donnelly-Roberts, D., Anderson, D. J., Bannon, A. W., Kang, C., Adams, P., Piattoni-Kaplan, M., Buckley, M. J., Gopalakrishnan, M., Williams, M. and Arneric, S. P., J. Pharmacol. Exp. Ther., 1994, 271, 624-631.
35. Grady, S., Marks, M. J., Wonnacott, S. and Collins, A. C., J. Neurochem., 1992, 59, 848-856.
36. Lloyd, G., McDonald, I., Vernier, J., Elliott, K., Ellis, S., Sacaan, A., Rao, T., Chavez-Noriega, L., Johnson, E., Velicelebi, F., Mengaghi, F. and Harpold, M., in "The cholinergic synapse: structure, function and regulation", Baltimore, 1994, 45.
37. Wilkie, G. I., Hutson, P. H., Stephens, M. W., Whiting, P. and Wonnacott, S., Biochem. Soc. Tran., 1993, 21, 429-431.
38. Thomas, P., Stephens, M., Wilkie, G., Amar, M., Lunt, G., Whiting, P., Gallaher, T., Pereira, E., Alkondon, M., Albuquerque, E. X. and Wonnacott, S., J. Neurochem., 1993, 60, 2308-2311.
39. Arneric, S. P., Sullivan, J. P., Briggs, C. A., Donnelly-Roberts, D., Anderson, D. J., Raszkiewicz, J. L., Hughes, M., Cadman, E. D., Adams, P., Garvey, D. S., Wasicak, J. and Williams, M., J. Pharmacol. Exp. Ther., 1994, 270, 310-318.
40. Wonnacott, S., Wilkie, G., Soliakov, L. and Whiteaker, P., in "Presynaptic nicotinic autoreceptors and heteroreceptors in the CNS", ed Clarke, P. B. S., Quik, M., Adlkofer, F. & Thurau, K., Birkhauser Verlag, Basel, 1995, 87-94.
41. Sullivan, J. and Bannon, A., CNS Drug Rev, 1996, 2, 21-39.
42. Bensimon, G., Lacomblez, L., Meininger, V. and Group, A. R. S., New Engl. J. Med., 1994, 330, 585-591.
43. Whitehouse, P. J., Martino, A., Antuono, P., Lowenstein, P., Coyle, J., Price, D. and Kellar, K., Brain Res., 1986, 371, 146-151.
44. Levin, E. D., Psychopharmacology, 1992, 108, 417-431.
45. Haroutunian, V., Barnes, E. and Davies, K. L., Psychopharmacology, 1985, 87, 266-271.
46. Decker, M. W., Brioni, J. D., Sullivan, J. P., Buckley, M. J., Radek, R. J., Raskiewickz, J. L., Kang, C. H., Kim, D. J. B., Giardina, W. J., Williams, M. and Arneric, S. P., J. Pharmacol. Exp. Ther., 1994, 270, 319-328.
47. Brioni, J. D. and Arneric, S. P., Behav. Neural Biol., 1993, 59, 57-62.
48. Buccafusco, J. and Jackson, W., Neurobiol. Aging, 1991, 12, 233-238.
49. Muir, J., Everitt, B. and Robbins, T., Psychopharmacology, 1995, in press,
50. Picciotto, M., Zoll, M., Lena, C., Bessis, A., Lallemand, Y., LeNovere, N., Vincent, P., Pich, E., Brulet, P. and Changeaux, J., Nature, 1995, 374, 65-67.
51. Brioni, J. D., Linville, D. G., Cadman, E. D., Buckley, M., Anderson, D. J. and Arneric, S. A., Soc. Neurosci. Abstr., 1991, 1236.
52. Decker, M. W., in "Neurotransmitter interactions and cognitive function", ed. Levin, E. D., Decker, M. W. & Butcher, L. L., Birkhauser, 1992, 78-90.
53. Wonnacott, S., Irons, J., Rapier, C., Thorne, B. and Lunt, G. G., in "Presynaptic modulation of transmitter release by nicolinic receptors", ed. Norberg, A., Fuxe, K., Holmstedt, B. & Sundwall, A., Elsevier, Amsterdam, 1990, 157-163.
54. Turchi, J., Holley, L. and Sarter, M., Paychopharmacology, 1995, 118, 195-205.
55. Janson, A., Fuxe, K., Agnati, L., Katayama, L, Harfstrand, A., Anderson, K. and Goldstein, M., Brain Res., 1988, 455, 332-345.
56. Owman, C., Fuxe, K., Jason, A. and Kahrstrom, J., Prog. Brain Res., 1989, 79, 267-276.
57. Chen, Y., Ogren, S., Bjelke, B., Bolme, P., Eneroth, P., Gross, J., Loidl, F., Herrera-Marschitz, M. and Anderson, K., Neuroscience, 1995, 68, 531-538.
58. Fuxe, K., Rosen, L., Lippoldt, A., Andbjer, B., Hasselrot, U., Finman, U. and Agnati, L., Clin Investig, 1994, 72, 262-268.
59. O'Neill, A., Morgan, S., Sykora, T., Postl, S. and Brioni, J., Soc. Neurosci. Abstr., 1996.
60. Sjak-Shie, N. and Meyer, E., Brain Res., 1993, 624, 295-298.
61. Lipton, S., Frosch, M., Phillips, M., Tauck, D. and Aizenman, E., Science, 1988, 239, 1293-1296.
62. Marin, P., Maus, M., Desagher, S., Glowinski, J. and Premont, J., NeuroReport, 1994, 5, 1977-1980.
63. Akaike, A., Tamura, Y., Yokaota, T., Shimohama, S. and Kimura, J., Brain Res., 1994, 644, 181-187.
64. Donnelly-Roberts, D., Xue, I., Arneric, S. and Sullivan, J., Brain Res., 1996, 719: 36-44.
65. Martin, E., Panickar, K., King, M., Deyrup, M., Hunter, B., Wang, G. and Meyer, E., Drug Dev. Res., 1994, 31, 135-141.
66. Ren, T. and Sagar, S. M., Brain Res. Bull., 1992, 29, 589-597.
67. Sullivan, J., Briggs, C., Donnelly-Roberts, D., Brioni, J., Radek, R., McKenna, D., Campbell, J., Arneric, S., Decker, M. and Bannon, A., Med. Chem. Res., 1994, 4, 502-516.
68. Perry, D. and Kellar, K., J. Pharmacol. Exp. Then, 1995, 275, 1030-1034.
69. Damaj, M., Creasy, K., Rosecrans, J. and Martin, B., Brain Res., 1994, 664, 34-40.
70. Scaan, A. I., Menzaghi, F., Dunlop, J. L., Correa, L. D., Whelan, K. T. and Lloyd, G. K., J. Pharmacol. Exp. Ther., 1996, 276, 509-515.
71. Reavill, C., Spivak, C., Stolerman, I. and Waters, J., Neuropharmacology, 1987, 26, 789-792.
72. Reavill, C., Waters, J., Stolerman, I. and Garcha, H., Psychopharmacology, 1990, 102, 521-528.
73. Buccafusco, L, Jackson, W., Gattu, M. and Terry, A., submitted.
74. Ward, J. and Merritt, L., J Heterocyclic Chem, 1990, 27, 1709-1712.
75. Meyer, E., Fiebre, C. d., Hunter, B., Simpkins, C., Frauworth, N. and Fiebre, N. d., Drug Dev. Res., 1994, 31, 127-134.
76. deFiebre, C. M., Meyer, E. M., Henry, J. C., Muraskin, S. I., Kem, W. R. and Papke, R. L., Mol. Pharmacol., 1995, 47, 164-171.
77. Arendash, G., Sengstock, G., Sanberg, P. and Kem, W., Brain Res., 1995, 674, 252-259.
78. Hunter, B., deFiebre, C., Papke, R., Kem, W. and Meyer, E., Neurosci. Lett., 1994, 168, 130-134.
79. Decker, M., Brioni, J., Bannon, A. and Americ, S., Life Sci., 1995, 56, 545-570.
80. Lloyd, G., Rao, T., Sacaan, A., Reid, R., Correa, L., Whelan, K., Risbrough, V. and Menzaghi, F., Soc. Neurosci. Abstr., 1995, 11.10.
81. Bencherif, M., Lovette, M., Arrington, S., Fowler, K., Reeves, L., Caldwell, W. and Lippiello, P., Soc. Neurosci. Abstr., 1995, 247.1.
82. Decker, M. W., Curzon, P., Brioni, J. D. and Arneric, S. P., Eur. J. Pharmacol., 1994, 261, 217-222.
83. Decker, M. W., Majchrzak, M. J. and Anderson, D. J., Brain Res., 1992, 572, 281-285.
84. Buccafusco, J., Jackson, W., Terry, A., Marsh, K., Decker, M. and Arneric, S., Psychopharmacology, 1995, 120, 256-266.
85. Brioni, J. D., O'Neill, A. B., Kim, D. J. B., Decker, M. W. and Arneric, S. P., J. Pharmacol. Exp. Ther., 1994, 271, 353-361.
86. Brioni, J. D., Kim, D. B. J., Brodie, M. S., Decker, M. W. and Arneric, S. P., Psychopharmacology, 1995, 107, 368-375.
87. Newhouse, P., Potter, A. and Corwin, J., Annual Conference of the Society for Research on Nicotine and Tobacco, Washington, DC, 1996, A39.
88. Lin, N., Gunn, D., Ryther, K., Garvey, D., Roberts, D., Decker, M., Brioni, J., Buckley, M., Rodriguez, A., Marsh, K., Anderson, D., Sullivan, J., Williams, M., Arneric, S. and Holladay, M., 1996, submitted.
89. Decker, M., Bannon, A., Curzon, P., Gunther, K., Brioni, J., Holladay, M., Lin, N., Daanen, J., Buccafusco, J., Prendergast, M., Jackson, W. and Arneric, S., J. Pharmacol. Exp. Ther., 1996, submitted.
90. Brioni, J., Kim, D., Brodie, M., Decker, M. and Arneric, S., 1996, submitted.
91. Arneric, S., Campbell, J., Holladay, M., Johnson, P., Lin, N., Marsh, K., Peterson, B., Hi, Y., Quigley, S., Roberts, E., Rodriguez, D., Sullivan, J., Trivedi, J. and Williams, M., J. Pharmacol. Exp. Ther., 1996, submitted.